By using siRNAs targeting AKT1-3, we observed that SHP099 significantly reduces the proliferation and colony formation of CRC cells (CaCO2 and SW480) as knocking down AKT (Supplementary Figures S3A–3B). This evidence concerns the gene AKT1 and colorectal carcinoma.